Home » Germany Permits Sale of Northwest Bio Brain Cancer Drug
Germany Permits Sale of Northwest Bio Brain Cancer Drug
German health regulators have granted Northwest Biotherapeutics special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small U.S. biotech has not yet completed its late-stage trial of the immunotherapy.
Reuters
Reuters
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May